Anaplastic large-cell lymphoma with atypical chromosomal translocation t(2;5) and hypophyseal tumor

av Wang, Lei, Tong, Yin, Chen, Zhimei, Xu, Weilai, Jin, Jie
Publicerad 2010

Downregulation of hTERT: An Important As(2)O(3) Induced Mechanism of Apoptosis in Myelodysplastic Syndrome

av Xu, Weilai, Wang, Yungui, Tong, Hongyan, Qian, Wenbin, Jin, Jie
I publikationen PLoS One (2014)

Efficacy and safety of homoharringtonine plus cytarabine and aclarubicin for patients with myelodysplastic syndrome-RAEB

av XIAO, FENG, LI, YING, XU, WEILAI, YOU, LIANGSHUN, YANG, CHUNMEI, LIU, HUI, QIAN, WENBIN
I publikationen Oncol Lett (2016)

Acute myocardial/cerebral infarction as first/relapse manifestation in one acute promyelocytic leukemia patient

av Li, Ying, Suo, Shanshan, Mao, Liping, Wang, Lei, Yang, Chunmei, Xu, Weilai, Lou, Yinjun, Mai, Wenyuan
I publikationen Int J Clin Exp Med (2015)

Lower-dose decitabine improves clinical response compared with best supportive care in lower-risk MDS patients: a prospective, multicenter phase 2 study

av Ye, Li, Mei, Chen, Ren, Yanling, Zhou, Xinping, Ma, Liya, Xu, Weilai, Wei, Juying, Jiang, Huifang, Zhang, Liming, Zeng, Hui, Tong, Hongyan
I publikationen J Cancer (2021)

Real‐world data of chronic myelomonocytic leukemia: A chinese single‐center retrospective study

av Ma, Liya, Jiang, Lingxu, Yang, Wenli, Luo, Yingwan, Mei, Chen, Zhou, Xinping, Xu, Gaixiang, Xu, Weilai, Ye, Li, Ren, Yanlin, Lu, Chenxi, Lin, Peipei, Jin, Jie, Tong, Hongyan
I publikationen Cancer Med (2021)

Mutation status and burden can improve prognostic prediction of patients with lower‐risk myelodysplastic syndromes

av Jiang, Lingxu, Luo, Yingwan, Zhu, Shuanghong, Wang, Lu, Ma, Liya, Zhang, Hua, Shen, Chuying, Yang, Wenli, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ye, Li, Xu, Weilai, Yang, Haiyang, Lu, Chenxi, Jin, Jie, Tong, Hongyan
I publikationen Cancer Sci (2019)

Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes

av Yan, Xuefen, Wang, Lu, Jiang, Lingxu, Luo, Yingwan, Lin, Peipei, Yang, Wenli, Ren, Yanling, Ma, Liya, Zhou, Xinping, Mei, Chen, Ye, Li, Xu, Gaixiang, Xu, Weilai, Yang, Haiyang, Lu, Chenxi, Jin, Jie, Tong, Hongyan
I publikationen Cancer Med (2021)

Impact of mutational variant allele frequency on prognosis in myelodysplastic syndromes

av Jiang, Lingxu, Wang, Lu, Shen, Chuying, Zhu, Shuanghong, Lang, Wei, Luo, Yingwan, Zhang, Hua, Yang, Wenli, Han, Yueyuan, Ma, Liya, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ye, Li, Xu, Weilai, Yang, Haiyang, Lu, Chenxi, Jin, Jie, Tong, Hongyan
I publikationen Am J Cancer Res (2020)

Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone

av Ye, Li, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ma, Liya, Ye, Xingnong, Wei, Juying, Xu, Weilai, Meng, Haitao, Qian, Wenbin, Mai, Wenyuan, Lou, Yinjun, Xu, Gaixiang, Qian, Jiejing, Lou, Yejiang, Luo, Yingwan, Xie, Lili, Lin, Peipei, Hu, Chao, Jin, Jie, Tong, Hongyan
I publikationen J Cancer Res Clin Oncol (2017)

The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes

av Lin, Peipei, Ren, Yanling, Yan, Xiaomei, Luo, Yingwan, Zhang, Hua, Kesarwani, Meenu, Bu, Jiachen, Zhan, Di, Zhou, Yile, Tang, Yuting, Zhu, Shuanghong, Xu, Weilai, Zhou, Xinping, Mei, Chen, Ma, Liya, Ye, Li, Hu, Chao, Azam, Mohammad, Ding, Wei, Jin, Jie, Huang, Gang, Tong, Hongyan
I publikationen Haematologica (2019)